Hydromorphone for cancer pain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hydromorphone for cancer pain

Published:2021-08-05 Issue:8 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Li Yan¹,Ma Jun²,Lu Guijun³,Dou Zhi⁴,Knaggs Roger⁵,Xia Jun⁶,Zhao Sai⁶,Dong Sitong⁷,Yang Liqiang⁴

Affiliation:

1. Department for Anesthesiology and Pain Management; The People's Hospital of Jizhou District, Tianjin; Tianjin China

2. Center for Anesthesiology; Beijing Anzhen Hospital, Capital Medical University; Beijing China

3. Pain Medicine Department; Beijing Tsinghua Changgung Hospital; Bejing China

4. Pain Medicine Department; Xuanwu Hospital, Capital Medical University; Beijing China

5. School of Pharmacy; University of Nottingham; Nottingham UK

6. Systematic Review Solutions Ltd; The Ingenuity Centre, The University of Nottingham; Nottingham UK

7. Division of Psychiatry and Applied Psychology, School of Medicine; University of Nottingham; Nottingham UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference85 articles.

1. Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: a randomized controlled trial;Banala;PloS One,2020

2. Hagen NA Babul N Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain Cancer 1997 79 7 1428 37

3. A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain;Hanna;BMC Palliative Care,2008

4. A study of OROS hydromorphone HCl vs morphine in cancer pain patients clinicaltrials.gov/ct2/show/NCT00410540

5. A randomised, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain relief);Inoue;Journal of Pain Research,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efeitos do uso de Cannabis medicinal no tratamento da dor relacionada ao câncer: uma revisão sistemática;ConScientiae Saúde;2024-09-05

2. Shifting Views on Cancer Pain Management: A Systematic Review and Network Meta-Analysis;Journal of Pain and Symptom Management;2024-09

3. Efficacy and safety of hydromorphone for cancer pain: a systematic review and meta-analysis;BMC Anesthesiology;2024-08-09

4. Effectiveness of Hydromorphone Hydrochloride Combined with Bupivacaine for Combined Spinal and Epidural Anaesthesia in Reducing Postpartum Urinary Retention: A Retrospective Study;Archivos Españoles de Urología;2024

5. New Targets for Cancer Pain Relief;Interdisciplinary Cancer Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3